The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Epidemic played large role in shift of attitudes on abortion, author says

June 25, 2010 6:35 am | by EurekAlert | News | Comments

(University of Illinois at Urbana-Champaign) Ten years before the 1973 Supreme Court decision legalizing abortion, German measles probably played the biggest part in starting to shift public attitudes about the criminal abortion laws, University of Illinois historian Leslie J....


A life-changing partnership

June 25, 2010 6:35 am | by EurekAlert | News | Comments

(European Molecular Biology Laboratory) Researchers at EMBL Heidelberg identified a novel regulatory protein complex in Drosophila that explains another protein's double life, and which likely plays an important role in mammals, too.


Eyegate Pharma begins trial for dry eye drug

June 25, 2010 6:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Eyegate Pharmaceuticals Inc. has launched a Phase 3 clinical trial for its drug target, called EGP-437, to treat dry eye syndrome. The drug candidate is a type of steroid, delivered using the company's proprietary, non-invasive delivery system, known as Eyegate II.


United Seating & Mobility Launches New Company Website and E-Commerce Store at

June 25, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

ALBUQUERQUE, N.M. , June 25 /- United Seating & Mobility, the nation's largest privately-owned mobility and rehab equipment supplier, launched a newly redesigned website today at . The new site features in-depth information for clients, families, and clinicians,...


Tolerx Presents Preclinical Data on Novel T-cell Modulator, TRX518, for Antitumor Immune Response at Federation of Clinical Immunology Societies Scientific Meeting

June 25, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass. , June 25 /- Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, presented results from preclinical studies with TRX518, an early-stage agent Tolerx is developing as a treatment for...


Leading Experts to Speak at Focused Ultrasound Symposium

June 25, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

Focused Ultrasound Surgery Foundation Announces Speakers, Moderators and Panelists for 2nd International Symposium on MR-Guided Focused Ultrasound CHARLOTTESVILLE, Va. , June 25 /PRNewswire-USNewswire/ -- Leading research and clinical experts from around the world are scheduled to speak...


1D and 2D Code Reader Is Extremely Small and Fast

June 25, 2010 6:29 am | Product Releases | Comments

The new Keyence SR-600 series Code Reader incorporates state of the art technology to provide a vision based reader capable of very high speed, reliability, and performance.

Calibrator Helps Ensure Accuracy Of Test Instruments

June 25, 2010 6:22 am | Product Releases | Comments

Fluke Corp., a leader in electronic test and measurement technology, has introduced the new Fluke 5080A Calibrator, engineered to accurately and easily calibrate both analog and digital test instruments.


Driver Boards Designed for Powering LED-Backlit LCDs

June 25, 2010 6:05 am | Product Releases | Comments

LCD backlit power specialist Endicott Research Group (ERG) is offering two new LED driver boards that provide compact, economical solutions to OEM panel designers looking to get the maximum performance out of their displays.

Improved Enclosed Hospital Grade Isolation Transformers Offer Lower Cost

June 25, 2010 5:56 am | Product Releases | Comments

The Tortran Division of Bridgeport Magnetics Group Inc. offers the ISO-PUCK II, a new line of enclosed hospital grade isolation transformers with more features and at significant cost savings to the buyer.

CGI Pharma to be sold to Calif. firm for $120M

June 25, 2010 5:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

CGI Pharmaceuticals Inc., a small-molecule-focused biotech in Branford, Conn., has signed a deal to be acquired by Gilead Sciences Inc. for up to $120 million. The buyout is planned to close in the third quarter of 2010.

Archimedes Pharma Receives CHMP Positive Opinion for PecFent(R) for the Treatment of Breakthrough Cancer Pain

June 25, 2010 5:34 am | by Bio-Medicine.Org | News | Comments

READING, England , June 25, 2010 /- Archimedes Pharma ("Archimedes"), a leading specialty pharma company, today announced that its lead product, PecFent*, has received a Positive Opinion from the Committee for Human Medicinal Products (CHMP), of the European Medicines Agency (EMA). The...


Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVaxâ„¢ Administration

June 25, 2010 5:34 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J. , June 25 /- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today the publication of an article in the June 2010 edition of Vaccine , which describes protection from mucosal and systemic ricin...


Phase 1 trial triggers $1M payment for ImmunoGen

June 25, 2010 5:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Biotech firm ImmunoGen Inc. is in line for a $1 million milestone payment from sanofi-aventis, now that sanofi has launched a Phase 1 clinical trial of ImmunoGen's SAR650984 investigational antibody.


Tenet Healthcare named AIG director to its board

June 25, 2010 3:45 am | by The Associated Press | News | Comments

Hospital operator Tenet Healthcare Corp. said Friday it named Ronald Rittenmeyer, former CEO of Electronic Data Systems Corp., to a vacancy on its board.Rittenmeyer, 63, replaces Don Williams, who retired from Tenet in May.Rittenmayer is the former chairman, president and CEO of EDS and has...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.